Amneal Makes First Biosimilar Launch With US Bevacizumab

Alymsys Rival To Avastin, Developed By mAbxience, Is Introduced In US

 
• By David Wallace
  
Amneal HQ building sign
Amneal has launched its first biosimilar • Source: Shutterstock

More from Biosimilars

More from Products